It was late december 2014 when pyc was granted a Genetech incentive deal of 142 million re: superbug potential (of memory december 21 or 22).
Now that pyc has handed over their in house research to Genetech we may see these advised efficacy results as early as xmas time 2016.
Point being, pyc is definately a good speculative buy at this current duscounted sp.., that is, part or partial, not to mention full forwarding if the 142 mil, will not only raise its current low market cap, but furthermore northbound the current sp. Luck to all holders and may santa cum early for pyc holders.
Add to My Watchlist
What is My Watchlist?
 (20min delay)
|
|||||
|
Last
$1.28 |
Change
0.020(1.59%) |
Mkt cap ! $743.6M | |||
| Open | High | Low | Value | Volume |
| $1.26 | $1.28 | $1.24 | $46.67K | 37.07K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 15857 | $1.26 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $1.30 | 700 | 1 |
View Market Depth
| Last trade - 16.10pm 30/07/2025 (20 minute delay) ? |
| PYC (ASX) Chart |